Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis
Clinical trial NCT05197842 · COMPLETED
Trial details
- NCT number
- NCT05197842
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-22
- Primary completion
- 2025-03-19
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.